Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

Clinical trial NCT06483074 · RECRUITING

Trial details

NCT number: NCT06483074
Sponsor: Chinese University of Hong Kong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease on Dialysis Peritoneal Dialysis Complication Sodium-glucose Cotransporter-2 Inhibitor Residual Kidney Function

Start date: 2024-07-29
Primary completion: 2026-07-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.